Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACS Appl Polym Mater ; 5(3): 2195-2202, 2023 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-37552750

RESUMO

The efficacy of coronavirus disease 2019 (COVID-19) vaccination is closely related to the serum levels of SARS-CoV-2-neutralizing antibodies (NAb) that bind to the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Therefore, the rapid and quantitative measurement of SARS-CoV-2 NAb in the sera of vaccinated individuals is essential to develop an effective vaccine and further achieve population immunity, that is, herd immunity. The plaque reduction neutralization test, the gold standard for NAb effectiveness in serological tests, is accurate but requires biosafety level 3 facilities because of the use of the virus, which hampers its application in common laboratories and clinical practice. Here, we developed a bioresponsive nanogel-based surface plasmon resonance (nSPR) platform that detects SARS-CoV-2 NAb in clinical samples without complicated pretreatment. We found that multivalent protein binding (MPB) between the nanogel-conjugated RBD protein and SARS-CoV-2 NAb yields significantly enhanced SPR signals compared to the nonspecific interference from serum proteins in the nSPR assay. The excellence of our nanogel-based SARS-CoV-2 NAb test is due to its selectivity for NAb, with resistance to all other proteins, allowing the rapid detection and quantification of NAbs in each individual. Importantly, this nSPR assay provides a NAb detection platform for easier and safer COVID-19 vaccination strategies.

2.
Artigo em Inglês | MEDLINE | ID: mdl-35886387

RESUMO

The COVID-19 pandemic is recognized as one of the most serious global health problems, and many countries implemented lockdown measures to mitigate the effects of the crisis caused by this respiratory infectious disease. In this study, we investigated the relationship between social distancing policies and changes in traffic volume in Sinchon Station, South Korea. We used an official COVID-19 report provided by the Korea Disease Control and Prevention Agency (KCDA) and Seoul Metropolitan Government (SMG) to review social distancing policies, and the changes in traffic patterns before and during the COVID-19 pandemic between January 2020 and November 2021 were analyzed. Our study reveals that the changes in the overall traffic patterns from acceleration phases to deceleration phases of COVID-19 were related to the alert levels of social distancing policies implemented to tackle the situation resulting from the COVID-19 pandemic. Herein, we found that a significant decline in traffic volume took place from August to September 2020 (13.5−19.7%, weekday; 19.4−31.7%, weekend), from December 2020 to January 2021 (20.0%−26.6%, weekday; 26.8−34.0%, weekend), and from July to September 2021 (3.2−13.1%, weekday; 38.3−44.7%, weekend) when compared to the corresponding periods in 2019 (paired t-test; p < 0.001). The results of this study provide strong support for the effectiveness of Seoul's preemptive measures, namely, the central government's intensive social distancing campaign, in managing and reducing the impact of the pandemic situation based on the precise analysis of 10 types of facilities.


Assuntos
COVID-19 , COVID-19/epidemiologia , COVID-19/prevenção & controle , Controle de Doenças Transmissíveis/métodos , Humanos , Pandemias/prevenção & controle , Distanciamento Físico , Políticas , República da Coreia/epidemiologia , SARS-CoV-2
3.
J Vet Sci ; 16(4): 431-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26040610

RESUMO

Monoclonal anti-enrofloxacin antibody was prepared for a direct competitive enzyme-linked immunosorbent assay (ELISA) and purification system using monoclonal antibody (mAb) coupled magnetic nanoparticles (MNPs). The IC50 values of the developed mAb for enrofloxacin (ENR), ciprofloxacin, difloxacin, sarafloxacin, pefloxacin, and norfloxacin were 5.0, 8.3, 9.7, 21.7, 36.0, and 63.7 ng/mL, respectively. The lowest detectable level of ENR was 0.7 ng/mL in the prepared ELISA system. To validate the developed ELISA in the food matrix, known amounts of ENR were spiked in meat and egg samples at 10, 20 and 30 ng/mL. Recoveries for ENR ranged from 72.9 to 113.16% with a coefficient of variation (CV) of 2.42 to 10.11%. The applicability of the mAb-MNP system was verified by testing the recoveries for ENR residue in three different matrices. Recoveries for ENR ranged from 75.16 to 86.36%, while the CV ranged from 5.08 to 11.53%. Overall, ENR-specific monoclonal antibody was prepared and developed for use in competitive to ELISAs for the detection of ENR in animal meat samples. Furthermore, we suggest that a purification system for ENR using mAb-coupled MNPs could be useful for determination of ENR residue in food.


Assuntos
Anticorpos Monoclonais/química , Antineoplásicos/análise , Ensaio de Imunoadsorção Enzimática/métodos , Fluoroquinolonas/análise , Contaminação de Alimentos/análise , Nanopartículas de Magnetita/química , Animais , Ovos/análise , Enrofloxacina , Feminino , Carne/análise , Camundongos , Camundongos Endogâmicos BALB C
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...